Capital Advisors Ltd’s Twist Bioscience TWST Stock Holding History

Capital Advisors Ltd’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-6	Closed	–	–	1653
2022 Q3	$0	Buy	+6	New	+$255	﹤0.01%	1527

Other funds holding TWST

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return

Capital Advisors Ltd's TWST Position: Q4 2022 in Review

Capital Advisors Ltd sold out of Twist Bioscience (TWST) in Q4 2022, closing a stake of 6 shares.

Capital Advisors Ltd first reported a position in TWST in Q3 2022 and held it in 1 quarter. The position peaked at $0 in Q3 2022. 198 funds tracked by Wall St. Rank hold TWST as of Q4 2022.

Capital Advisors Ltd reported no remaining Twist Bioscience position as of Q4 2022 after selling out during the quarter.
Capital Advisors Ltd sold 6 Twist Bioscience shares in Q4 2022.
Capital Advisors Ltd first reported a position in Twist Bioscience in Q3 2022 and held it in 1 quarter.
Capital Advisors Ltd's Twist Bioscience position peaked at $0 in Q3 2022.
198 funds tracked by Wall St. Rank held Twist Bioscience as of Q4 2022.

Based on Capital Advisors Ltd's 13F filing for Q4 2022, filed 7 Feb 2023.